In vitro activity of diospyrin and derivatives against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei brucei

Phytotherapy Research

Volumn 10, Issue 7, 1996, Pages 559-562

  Yardley, Vanessa ^a   Snowdon, Diane ^a   Croft, Simon ^a   Hazra, Banasri ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b JADAVPUR UNIVERSITY   (India)

Author keywords

Antiprotozoal; Diospyrin; Leishmania; Naphthoquinone; T. brucei; T. cruzi

Indexed keywords

ANTIPROTOZOAL AGENT; DIOSPYRIN; DIOSPYRIN DERIVATIVE; NIFURTIMOX; PENTAMIDINE; STIBOGLUCONATE SODIUM; UNCLASSIFIED DRUG;

AMASTIGOTE; ANIMAL CELL; ANIMAL MODEL; ANTIPROTOZOAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ISOLATION; DRUG SYNTHESIS; EXPERIMENTAL INFECTION; HAMSTER; LEISHMANIA DONOVANI; MACROPHAGE; MALE; MOUSE; NONHUMAN; SPECTROSCOPY; TRYPANOSOMA BRUCEI; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE;

ANIMALIA; CRICETINAE; LEISHMANIA DONOVANI; TRYPANOSOMA; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMA CRUZI;

EID: 0029846752     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1573(199611)10:7<559::AID-PTR891>3.0.CO;2-V     Document Type: Article

References (25)

1. Bacchi, C. J., Garofolo, J., Ciminelli, M., et al. (1993). Resistance to DL-difluoromethylornithine by clinical isolates of Trypanosoma brucei rhodesiense. Role of S-adenosyl methionine. Biochem. Pharmacol. 46, 471-481.
2. Bachur, N. R., Gordon, S. L., and Gee, M. V. (1978). A general mechanism for microsomal activation of quinone anticancer agents to free radicals. Cancer Res. 38, 1745-1750.
3. Croft, S. L., Evans, A. T., and Neal, R. A. (1985). The activity of plumbagin and other electron carriers against Leishmania donovani and Leishmania mexicana amazonensis. Ann. Trop. Med. Parasitol. 79, 651-653.
4. Croft, S. L., Hogg, J., Gutteridge, W. E., Hudson, A. T., and Randall, A. W. (1992). The activity of hydroxynaphthoquinones against Leishmania donovani. J. Antimicrob. Chemother. 30, 827-332.
5. De Castro, S. L. (1993). The challenge of Chagas' disease chemotherapy: an update of drugs assayed against Trypanosoma cruzi, Acta Trop. 53,83-98.
6. Docampo, R., and Moreno, S. N. J. (1984). Free radical metabolites in the mode of action of chemotherapeutic agents and phagocytic cells in Trypanosoma cruzi. Rev. Infect. Dis. 6, 223-238.
7. Ellis, J. E. (1994). Coenzyme Q homologs in parasitic protozoa as targets for chemotherapeutic attack. Parasitology Today 10, 297-301.
8. Fournet, A., Barrios, A. A., Munoz, V., Hocquemiller, R., and Cave, A. (1992). Effect of natural naphthoquinones in BALB/c mice infected with Leishmania amazonensis & Leishmania venezuelensis. Trop. Med. Parasitol. 43, 219-222.
9. Goncalves, A. M., Vasconcellos, M. E., Docampo, R., Cruz, D. Souza, F. S., and Leon, W. (1980). Evaluation of the toxicity of 3-allyl-β-lapachone against Trypanosoma cruzi. Mot. Biochem. Parasitol. 72, 159-176.
10. Hazra, B., Banerjee, A., and Roy, D. K. (1986). Inhibitory activity of diospyrin towards L. donovani promastigotes in vitro. IRCS Med. Sci. 14, 593-594.
11. Hazra, B., Ghosh, R., Banerjee A. Kirby. G. C., Warhurst, D. C., Phillipson, J. D. (1995). In vitro antiplasmodial effects of diospyrin, a plant-derived naphthoquinoid and a novel series of derivatives. Phyrother. Res. 9, 72-74.
12. Hazra, B., Pal, S., and Banerjee, A. (1994a). New diospyrin derivatives with improved inhibitory activity towards Ehrlich ascites carcinoma. Med. Sci. Res. 22, 351-353.
13. Hazra, B., Pal, S., Ghosh, R., and Banerjee, A. (1994b). Studies on the changes of the tumour-inhibitory activities through structural modification of a diospyrin derivative. Med. Sci. Res. 22, 621-623.
14. Hazra, B., Saha, A. K., Ray, R., Roy, D. K., Sur, P., and Banerjee, A. (1987). Antiprotozoal activity of diospyrin towards Leishmania donovani promastigotes in vitro. Trans. Trop. Med Hyg. 81, 738-741.
15. Hazra, B., Sur, P., Sur, B., Banerjee, A., and Roy, D. K. (1984). Studies on the biological activity of diospyrin towards Ehrlich ascites carcinoma in Swiss A mice. Planta Med. 58, 295-298.
16. Hirumi, H. and Hirumi, K. (1994). Axenic culture of African Trypanosome bloodstream forms. Parasitol. Today 10, 80-84.
17. Hudson, A. T. (1984). Lapinone, menoctone, hydroxyquinoline-quinones and similar structures. In, Handbook of Experimental Pharmacology, 68, Antimalarial Drugs, Vol. 2, ed. by W. Peters and W. H. G. Richards, pp. 343-361. Springer Verlag, Berlin.
18. Hudson, A. T. (1993). Atovaquone - a novel broad-spectrum anti-infective drug. Parsitol. Today 9, 66-68.
19. Iwu, M. M., Jackson, J. E. and Schuster, B. G. (1994). Medicinal plants in the fight against leishmaniasis. Parasitol Today 10, 65-68.
20. Kovacic, P., Ames, J. R., Grogan, J. W., Hazra, B., and Ryan, M. D. (1988). Anticancer quinones and quinolines. Mode of action via electron transfer and oxidative stress. In, Redox Chemistry and Interfacial Behavior of Biological Molecules, ed. by G. Dryhurst and K. Niki, pp. 295-307. Plenum Press, New York.
21. Neal, R. A., and Croft, S. L. (1984). An in vitro system for determining the activity of compounds against the intracellular amastigote form of Leishmania donovani.-J. Antimicrob. Chemother. 14, 463-475.
22. Olliaro, P. O., and Bryceson, A. D. M. (1993). Practical progress and new drugs for changing patterns of leishmaniasis. Parasitol. Today 9, 323-328.
23. Pepin, J., and Milord, F. (1994). The treatment of human African trypanosomiasis. Adv. Parasitol. 33, 1-97.
24. Thompson, D. C., Thompson, J. A., Sugumaran, M. and Peter, M. (1992). Biological and toxicological consequences of quinone methide formation. Chem. Biol. Interact. 86, 129-162.
25. Wright, C. W., and Phillipson, J. D. (1990). Natural products and the development of selective antiprotozoal drugs. Phytother. Res. 4, 127-139.